End-to-end invaginated pancreaticojejunostomy during minimally invasive pancreatoduodenectomy: technical description

Manuel Barberio1,2, Antonio Milizia3,4, Margherita Pizzicannella3,5

  • 1Department of Surgery, Ospedale Card. G. Panico, Via Pio X 4, 73039, Tricase, Italy. manuel.barberio@ircad.fr.

Surgical Endoscopy
|August 2, 2023
PubMed
Abstract

Insights

This study introduces a modified minimally invasive end-to-end invaginated pancreaticojejunostomy (EIPJ) for pancreatic surgery. The technique is safe, easy, and effective for experienced surgeons, with acceptable short-term outcomes in pancreatic fistula rates.

Area of Science:

  • Surgical Innovation
  • Hepatobiliary and Pancreatic Surgery
  • Minimally Invasive Surgery

Background:

  • Minimally invasive pancreatoduodenectomy (MIPD) is a complex abdominal surgery with ongoing debate on optimal pancreatic stump management.
  • Pancreatic anastomosis techniques are critical for successful outcomes in MIPD.

Purpose of the Study:

  • To describe a novel modified minimally invasive end-to-end invaginated pancreaticojejunostomy (EIPJ) technique.
  • To evaluate the short-term outcomes of MIPD using the EIPJ reconstruction method.

Main Methods:

  • Retrospective analysis of 67 consecutive minimally invasive MIPD cases (laparoscopic and robotic).
  • Detailed description of the modified EIPJ technique using an intra-ductal anastomotic plastic stent.
  • Evaluation of operative time, biochemical leaks, and clinically relevant pancreatic fistulas.

Main Results:

  • The mean operative time for EIPJ was 21.57 ± 3.32 minutes.
  • Biochemical leaks occurred in 10.5% of patients.
  • Clinically relevant pancreatic fistulas (Grade B or C) were observed in 19.4% of patients.

Conclusions:

  • The modified EIPJ is a safe and easy-to-perform anastomosis for MIPD.
  • The technique is effective in experienced hepatobiliopancreatic (HBP) surgeons performing minimally invasive surgery.
  • Early results suggest favorable outcomes for MIPD with EIPJ.